US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
OCUL holding history
Ocular Therapeutix, Inc in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings
- Shares (Q2 2026)
- 447
- Value
- $4.39K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 447 | $4.39K | <0.1% | −21−4.5% | Reduced | Holders |
| Q1 2026 | 468 | $3.96K | <0.1% | +214+84.3% | Added | Holders |
| Q4 2025 | 254 | $3.08K | <0.1% | −128−33.5% | Reduced | Holders |
| Q3 2025 | 382 | $4.47K | <0.1% | −21−5.2% | Reduced | Holders |
| Q2 2025 | 403 | $3.74K | <0.1% | −212−34.5% | Reduced | Holders |
| Q1 2025 | 615 | $4.51K | <0.1% | +298+94.0% | Added | Holders |
| Q4 2024 | 317 | $2.71K | <0.1% | −578−64.6% | Reduced | Holders |
| Q3 2024 | 895 | $7.79K | <0.1% | −1,460−62.0% | Reduced | Holders |
| Q2 2024 | 2,355 | $16.1K | <0.1% | +2,355 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −3,011−100.0% | Sold out | Holders |
| Q3 2022 | 3,011 | $12.0K | <0.1% | +3,011 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −707−100.0% | Sold out | Holders |
| Q4 2021 | 707 | $5.00K | <0.1% | −81,793−99.1% | Reduced | Holders |
| Q3 2021 | 82,500 | $825.0K | <0.1% | −274−0.3% | Reduced | Holders |
| Q2 2021 | 82,774 | $1.17M | <0.1% | −198−0.2% | Reduced | Holders |
| Q1 2021 | 82,972 | $1.36M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.